Exchange of anti-epidemic practice

Emergency transformation experience of the laboratory department of a hospital designated for admission of patients with novel coronavirus infection in emergency conversion

Expand
  • Department of Clinical Laboratory, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2022-03-25

  Online published: 2022-04-25

Abstract

In late February 2021, a round of indigenous novel coronavirus (referred to as COVID-19) infection emerged in Shanghai, making the COVID-19 outbreak shift from regular prevention and control to drastic pandemic prevention and control measures. According to the requirements of the Guidelines for the Organization and Implementation of Regional Novel Coronavirus Nucleic Acid Testing (Third Edition) issued by the National Health and Wellness Commission, medical institutions at all levels with nucleic acid testing capabilities rapidly carried out novel coronavirus nucleic acid testing, which put forward higher requirements for testing and prevention and control for the emergency conversion of non-designated admission hospitals to designated hospitals. As a clinical department with close contact with novel coronavirus testing specimens, the department of clinical laboratory has long working hours and high work intensity, as well as the potential risk of aerosol and contact transmission of clinical routine specimens and nucleic acid specimens, which requires more improvement from human resource planning, laboratory nucleic acid testing, laboratory infection prevention and control, medical material security, and staff psychological guidance. In this paper, we hope to combine the practice of emergency transformation work of the laboratory department in the northern hospital area of Ruijin Hospital, including personnel allocation, planning of testing items for clinical samples, and establishment of emergency nucleic acid testing, to carry out relevant work in a scientific, standardized and orderly manner, and provide our associate organizations with valuable experience in the coordination and management of emergency testing in the laboratory department in response to the novel coronavirus outbreak.

Cite this article

MENG Jun, JIN Peipei, CHEN Changqiang, CHEN Jiuming, FAN Zhenjia, CHEN Shikai, DAI Jing, et al . Emergency transformation experience of the laboratory department of a hospital designated for admission of patients with novel coronavirus infection in emergency conversion[J]. Journal of Diagnostics Concepts & Practice, 2022 , 21(02) : 184 -188 . DOI: 10.16150/j.1671-2870.2022.02.016

References

[1] 梁万年, 姚建红, 吴敬, 等. 我国新型冠状病毒肺炎疫情防控常态化阶段的经验与思考[J]. 中华医学杂志, 2021, 101(10):695-699.
[1] Liang WN, Yao JH, Wu J, et al. Experience and Thinking on the normalization stage of prevention and control of novel coronavirus pneumonia in China[J]. Natl Med J Chin, 2021, 101(10):695-699.
[2] Zhang X, Zhang W, Chen S. Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic[J]. Lancet, 2022: S0140-6736(22)00838-8.
[3] Rahbari R, Moradi N, Abdi M. rRT-PCR for SARS-CoV-2: Analytical considerations[J]. Clin Chim Acta, 2021, 516:1-7.
[4] 国务院应对新型冠状病毒肺炎疫情联防联控机制综合组. 区域新型冠状病毒核酸检测组织实施指南(第三版)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7659/202203/b5aaa96dfe1b4f14b19bf2f888a10673.shtml.
[4] Comprehensive group of the State Council on joint prevention and control mechanism for novel coronavirus pneumonia. Regional guidelines for the organization and implementation of nucleic acid detection of novel coronavirus (Third Edition)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7659/202203/b5aaa96dfe1b4f14b19bf2f888a10673.shtml.
[5] 广州实验室新型冠状病毒核酸应急检测专家组. 大规模多场景移动实验室新型冠状病毒核酸应急检测专家共识[J]. 中华医学杂志, 2021, 101(40):3271-3277.
[5] Emergency detection expert group of novel coronavirus nucleic acid in Guangzhou Laboratory. Expert consensus on emergency detection of novel coronavirus nucleic acid in large-scale multi scene mobile laboratory[J]. Natl Med J Chin, 2021, 101(40):3271-3277.
[6] 林南清, 宋国伟. 检验人员的职业暴露及生物安全防护[J]. 检验医学与临床, 2011, 8(6):767-767.
[6] Lin NQ, Song GW. Occupational exposure and biosafety protection of inspectors[J]. Lab Med Clin, 2011, 8(6):767-767.
[7] 周帅锋, 李世康, 陈雨, 等. 微滴式数字PCR和实时荧光定量PCR对新型冠状病毒肺炎患者不同时间血便尿中核酸检测结果初步探讨[J]. 实用预防医学, 2020, 27(11):1316-1320.
[7] Zhou SF, Li SK, Chen Y, et al. Detection of nucleic acid in blood, stool and urine of patients with novel coronavirus pneumonia at different times by micro drop digital PCR and real-time fluorescent quantitative PCR[J]. Pract Prev Med, 2020, 27(11):1316-1320.
[8] 中华人民共和国国务院. 病原微生物实验室生物安全管理条例[EB/OL]. 2010-12-31[2020-02-24]. .
[8] State Council of the PRC. Regulations on biosafety management of pathogenic microorganism laboratory[EB/OL]. 2010-12-31[2020-02-24]. .
[9] 中华人民共和国国务院. 医疗废物管理条例[EB/OL]. 2003-06-04[2020-02-24]. .
[9] State Council of the PRC. Regulations on the administration of medical waste[EB/OL]. 2003-06-04[2020-02-24]. .
[10] 中华人民共和国国家质量监督检验检疫总局, 中国国家标准化管理委员会. GB 19489-2008 实验室生物安全通用要求[S]. 北京: 中国标准出版社, 2008.
[10] General Administration of quality supervision, inspection and Quarantine of the people's Republic of China, China National Standardization Administration Committee. GB 1948-2008 General requirements for laboratory biosafety[S]. Beijing: China Standards Press, 2008.
[11] 国务院应对新型冠状病毒肺炎疫情联防联控机制医疗救治组. 医疗机构新型冠状病毒核酸检测工作手册(试行第二版)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7659/202012/b89bcd0813da41788688eb14787b3c72.shtml.
[11] Medical treatment team of the State Council for joint prevention and control of novel coronavirus pneumonia.. Working manual for nucleic acid detection of novel coronavirus in medical institutions (trial version 2)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7659/202012/b89bcd0813da41788688eb14787b3c72.shtml.
[12] 国家卫生健康委办公厅. 新型冠状病毒实验室生物安全指南(第二版)[EB/OL]. http://www.nhc.gov.cn/xcs/zhengcwj/202001/0909555408d842a58828611dde2e6a26.shtml.
[12] General Office of National Health Commission. Laboratory biosafety guidelines for novel coronavirus (Second Edition)[EB/OL]. http://www.nhc.gov.cn/xcs/zhengcwj/202001/0909555408d842a58828611dde2e6a26.shtml.
[13] 程丽, 郑丽平, 晏苏玉, 等. 新型冠状病毒肺炎患者焦虑现状及影响因素分析[J]. 浙江医学, 2020, 42(4):315-317.
[13] Chen L, Zhen LP, Yan SY, et al. Analysis of anxiety status and influencing factors in patients with novel coronavirus pneumonia[J]. Zhejiang Med J, 2020, 42(4):315-317.
[14] 马翠, 严兴科. 新型冠状病毒肺炎疫情的心理应激反应和防控策略研究进展[J]. 吉林大学学报(医学版), 2020, 46(3):649-654.
[14] Ma C, Yan XK. Research Progress on psychological stress response and prevention and control strategy of novel coronavirus pneumonia[J]. J Jilin Univ (Med Ed), 2020, 46(3):649-654.
[15] 龚娅, 刘志强, 段德令, 等. 新型冠状病毒肺炎疫情非定点医院检验科整体防护策略[J]. 国际检验医学杂志, 2020, 41(19):2429-2432.
[15] Gong Y, Liu ZQ, Duan DL, et al. Overall protection strategy of laboratory departments in non designated hospitals in the epidemic situation of novel coronavirus pneumonia[J]. Int J Lab Med, 2020, 41(19):2429-2432.
[16] 中华人民共和国中央人民政府. 突发公共卫生事件应急条例[EB/OL]. [2021-03-12].
[16] The Central People's Government of the People's Republic of China. Regulations on emergency response to public health emergencies[EB/OL]. [2021-03-12].
Outlines

/